Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.

Medulloblastoma is the most common malignant brain tumor in children. It has WNT-driven, SHH-driven/TP53 mutant, SHH-driven/TP53 wildtype, and non-WNT/non-SHH subgroups. MAGMAS (Mitochondrial Associated Granulocyte Macrophage colony-stimulating factor Signaling molecules) encodes a mitochondrial imp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zahra Motahari, Javier J Lepe, Malia R Bautista, Clay Hoerig, Ashley S Plant-Fox, Bhaskar Das, Christie D Fowler, Suresh N Magge, Daniela A Bota
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2024-01-01
coleção:	PLoS ONE
Acesso em linha:	https://doi.org/10.1371/journal.pone.0300411
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!